— Know what they know.
Not Investment Advice

LITH OTC

BioELife Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $941 mcap · 7M float · 0.0065% daily turnover · Short 98% of daily vol

Balance Sheet Trends

Total Assets
$140K -62.8% ▼
5Y CAGR: +98.7%
Total Liabilities
$465K +4.0% ▲
5Y CAGR: +8.5%
Shareholders Equity
-$325K -360.5% ▼
Cash & Investments
$125K +25398.2% ▲
5Y CAGR: +94.2%
Total Debt
$280K +0.6% ▲
5Y CAGR: +4.4%
Net Debt
$275K -0.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2014FY2015FY2016FY2017FY2018
— Assets —
Cash$256$1K$8K$490$4K
Short-Term Investments$0$0$0$0$121K
Cash & ST Investments$256$1K$8K$490$125K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$9K$0$0
Total Current Assets$256$1K$17K$490$125K
Property, Plant & Equip.$0$0$14K$376K$15K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$14K$376K$15K
Total Assets$256$1K$31K$377K$140K
— Liabilities —
Accounts Payable$59K$68K$83K$114K$131K
Short-Term Debt$228K$57K$170K$278K$280K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$353K$210K$322K$447K$465K
Long-Term Debt$16K$10K$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$16K$10K$0$0$0
Total Liabilities$369K$219K$322K$447K$465K
— Equity —
Common Stock$46K$91K$91K$100K$3K
Retained Earnings-$969K-$1M-$1M-$2M-$2M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$368K-$218K-$290K-$71K-$325K
Total Liabilities & Equity$256$1K$31K$377K$140K
— Key Metrics —
Total Debt$244K$67K$170K$278K$280K
Net Debt$244K$66K$162K$277K$275K
Total Investments$0$0$0$0$121K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms